Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastoma
Pushan Dasgupta
Heather Lin
Gayatri Kumar
Zaid Soomro
Max M. Ayala
Edwin R. Parra
Shiao-Pei Weathers
Frederick F. Lang
Krishna P. Bhat
John de Groot
Nazanin K. Majd
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1007/s11060-025-05131-9
Jun 25, 2025
Version published to 10.21203/rs.3.rs-6649860/v1 on Research Square
May 16, 2025
Related articles
Timing Matters: Overall Treatment Time, Radiotherapy Interruptions, and Outcomes in glioblastomas – Prognostic Significance in Different Biological Sub- Groups
This article has 11 authors:
Paolo Tini
Flavio Donnini
Francesco Marampon
Pierpaolo Pastina
Giovanni Rubino
Giuseppe Battaglia
Salvatore Chibbaro
Alfonso Cerase
Maria Antonietta Mazzei
Isacco Desideri
Giuseppe Minniti
Optic pathway glioma: current treatment approaches and ongoing clinical trials—a review article
This article has 5 authors:
Osama Elzaafarany
Sarah Elhomosany
Alexandra Rincones
Vincent Dlugi
Sepideh Mokhtari
Cell-of-origin and genetic drivers define advanced bladder cancer subtypes and potential therapeutic response in mouse models
This article has 15 authors:
Ester Munera-Maravilla
Mercedes Pérez-Escavy
Carolina Rubio
Cristina Segovia
Iris Lodewijk
Sandra P. Nunes
Álvaro Martín de Bernardo
Ignacio A. Reina
Esther Montesinos
Lucía Morales
Víctor G. Martínez
Mónica Martínez-Fernández
Marta Dueñas
Jesús M. Paramio
Cristian Suárez-Cabrera
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up